Sep 22, 2019
Link REIT and Allinfra announce an agreement to collaborate on the use of blockchain technology for the tokenization of assets
Sep 22, 2019
Award-winning 360 Invention world launching @ INDIEGOGO! "360 Everywhere Enablers" are CALLED TO JOIN & CREATE With RSD360 "360 Everywhere" OPEN hardware & software !
Sep 22, 2019
Lleida.net Signs Two Interconnection Agreements With China Mobile and China Telecom and Will Have Access to One Billion Chinese Customers
Sep 22, 2019
Keysight Technologies to Award $50,000 USD to Winner of IoT Innovation Challenge
Sep 21, 2019
sPower Closes Debt and Tax Equity Financing for 218 MW Wind Farm
Sep 21, 2019
iBox: The First Universal and Validated Tool for Predicting the Risk of Kidney Transplant Loss
Sep 21, 2019
These NJ Top Docs Are Ready To Help Heal Your Summertime Skin
Sep 21, 2019
Young Activists Call for Presidential Candidates to Address Health & Economic Impacts of Alzheimer's Disease
Sep 21, 2019
StatLab Medical Products Granted Patent for Tissue Microarray Controls
Sep 21, 2019
Best, Worst and Riskiest Places to Sell a Phone in 2019? Flipsy.com In-Depth Breakdown
Sep 21, 2019
Fifteen Non-Profit Organizations Raise Nearly $10,000 from Infinity Federal Credit Union's Fifth Annual Parking for a Purpose
Sep 21, 2019
Bras de fer entre Airbus et le gouvernement espagnol
Sep 21, 2019
Airbus irked by Spain's choice of fighter jet partner
Sep 21, 2019
How To Get Affordable Car Insurance For High-Risk Drivers
Sep 21, 2019
ImPACT Applications and Player's Health Partner to Make FDA Cleared Concussion Testing Accessible to Sports Organizations
Sep 21, 2019
Why Drivers Should Keep The Same Car Insurance Company?
Sep 21, 2019
Radco Industries sponsors Mason Cullen, of the Mason Cullen 5 racing team, with Radcolube® CLP GUN OIL in Lucas Oil Nationals Series.
Sep 21, 2019
AXEL Announces Official Token Listing on ProBit Exchange
Sep 21, 2019
Herta Leads Honda Sweep Indy Car Qualifying In Monterey
Sep 21, 2019
2019 CSCO | CStone announces preliminary results from Phase I trial of CS1002 demonstrating characteristics comparable to ipilimumab

Pages